An immune cell that helps set the daily rhythms of the digestive system has been identified by researchers at Washington University School of Medicine in St. Louis. The findings open the door to new ...
SAN DIEGO -- Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) compared with standard best care, a randomized trial showed. Among ...
The real-world effects of biologic therapy for inflammatory bowel disease (IBD) do not match the promising outcomes observed in randomized controlled trials, a study has shown. Rather than being a ...
Immunai collected a hefty $215 million series B round back in 2021 after raising $60 million through a series A earlier that same year. Those funds have helped the company stretch its reach from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback